• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The influence of ill-health experience on the valuation of health.

作者信息

Badia X, Herdman M, Kind P

机构信息

Institut de Salut Pública de Catalunya, University of Barcelona, L'Hospitalet de Llobregat, Spain.

出版信息

Pharmacoeconomics. 1998 Jun;13(6):687-96. doi: 10.2165/00019053-199813060-00005.

DOI:10.2165/00019053-199813060-00005
PMID:10179704
Abstract

Social valuations for health states are potentially useful both in clinical decision-making and in health-resource allocation, but there is some evidence that the experience of illness may affect such valuations. This article compares valuations of hypothetical health states obtained from a sample of chronically ill patients, with valuations obtained from a sample of relatively healthy individuals. The instrument used to obtain these values was the EuroQOL 5D questionnaire (EQ-5D). We found that the EQ-5D values of chronically ill patients differed significantly from the values obtained from healthier individuals, particularly in the case of the more severe health states. Healthy individuals assigned negative values to some hypothetical health states, indicating that they consider them to be worse than death, whereas chronically ill patients assigned positive values to all health states. These results raise difficult questions about whose values should count when health-status measures are incorporated in clinical and economic evaluation, and in particular when deciding upon the allocation of scarce resources.

摘要

相似文献

1
The influence of ill-health experience on the valuation of health.
Pharmacoeconomics. 1998 Jun;13(6):687-96. doi: 10.2165/00019053-199813060-00005.
2
Social valuation of EQ-5D health states: the Chilean case.社会对 EQ-5D 健康状况的评估:智利案例。
Value Health. 2011 Dec;14(8):1135-41. doi: 10.1016/j.jval.2011.09.002. Epub 2011 Nov 6.
3
Quality-of-life valuations of advanced breast cancer by New Zealand women.新西兰女性对晚期乳腺癌的生活质量评估。
Pharmacoeconomics. 2006;24(3):281-92. doi: 10.2165/00019053-200624030-00007.
4
Why do patients with inflammatory arthritis often score states "worse than death" on the EQ-5D? An Investigation of the EQ-5D classification system.为什么炎症性关节炎患者在EQ-5D量表上的评分常常表明“比死亡还糟糕”?EQ-5D分类系统的一项调查。
Value Health. 2009 Sep;12(6):1026-34. doi: 10.1111/j.1524-4733.2009.00565.x. Epub 2009 May 15.
5
A social preference valuations set for EQ-5D health states in Flanders, Belgium.比利时佛兰德地区的 EQ-5D 健康状态社会偏好值集。
Eur J Health Econ. 2010 Apr;11(2):205-13. doi: 10.1007/s10198-009-0167-0. Epub 2009 Jul 7.
6
Hispanic valuation of the EQ-5D health states: a social value set for Latin Americans.西班牙裔对EQ-5D健康状态的估值:拉丁美洲人的社会价值集。
Value Health. 2008 Dec;11(7):1170-7. doi: 10.1111/j.1524-4733.2008.00349.x. Epub 2008 May 16.
7
Estimation and comparison of EQ-5D health states' utility weights for pneumococcal and human papillomavirus diseases in Argentina, Chile, and the United Kingdom.评估和比较阿根廷、智利和英国的肺炎球菌病和人乳头瘤病毒病的 EQ-5D 健康状况效用权重。
Value Health. 2011 Jul-Aug;14(5 Suppl 1):S60-4. doi: 10.1016/j.jval.2011.05.007.
8
Valuation of EuroQOL (EQ-5D) health states in an adult US sample.美国成年样本中欧洲生活质量五维度量表(EQ-5D)健康状态的评估
Pharmacoeconomics. 1998 Apr;13(4):421-33. doi: 10.2165/00019053-199813040-00005.
9
Learning effects in time trade-off based valuation of EQ-5D health states.基于时间权衡法的 EQ-5D 健康状态估值中的学习效应。
Value Health. 2012 Mar-Apr;15(2):340-5. doi: 10.1016/j.jval.2011.10.010. Epub 2012 Jan 27.
10
Productivity costs in health-state valuations : does explicit instruction matter?健康状态评估中的生产力成本:明确的指导重要吗?
Pharmacoeconomics. 2006;24(4):401-14. doi: 10.2165/00019053-200624040-00009.

引用本文的文献

1
Test-retest reliability of the Online Elicitation of Personal Utility Functions (OPUF) approach for valuing the EQ-HWB-S.用于评估EQ-HWB-S的个人效用函数在线诱导法(OPUF)的重测信度。
Eur J Health Econ. 2025 Mar 8. doi: 10.1007/s10198-025-01769-4.
2
Prophylactic Radiotherapy Of MInimally Symptomatic Spinal Disease (PROMISSeD): study protocol for a randomized controlled trial.无症状性脊柱疾病预防性放疗(PROMISSeD):一项随机对照试验的研究方案。
Trials. 2024 Jan 12;25(1):41. doi: 10.1186/s13063-023-07850-8.
3
Estimating an EQ-5D-3L Value Set for Romania Using Time Trade-Off.

本文引用的文献

1
EuroQol: the current state of play.欧洲生活质量量表:当前进展情况
Health Policy. 1996 Jul;37(1):53-72. doi: 10.1016/0168-8510(96)00822-6.
2
Eliciting EuroQol descriptive data and utility scale values from inpatients. A feasibility study.从住院患者中获取欧洲五维健康量表描述性数据和效用值:一项可行性研究。
Pharmacoeconomics. 1995 Aug;8(2):147-58. doi: 10.2165/00019053-199508020-00006.
3
Health state valuations from the general public using the visual analogue scale.使用视觉模拟量表对公众健康状况进行评估。
使用时间权衡法估算罗马尼亚的 EQ-5D-3L 值集。
Int J Environ Res Public Health. 2021 Jul 11;18(14):7415. doi: 10.3390/ijerph18147415.
4
Assessing the reliability and validity of the ICECAP-A instrument in Chinese type 2 diabetes patients.评估ICECAP-A工具在中国2型糖尿病患者中的信度和效度。
Health Qual Life Outcomes. 2021 Jan 6;19(1):5. doi: 10.1186/s12955-020-01632-5.
5
Treatment preferences in human papillomavirus-associated oropharyngeal cancer.人乳头瘤病毒相关性口咽癌的治疗偏好。
Future Oncol. 2018 Oct;14(24):2521-2530. doi: 10.2217/fon-2018-0063. Epub 2018 Sep 28.
6
Head-to-Head Comparison of EQ-5D-3L and EQ-5D-5L Health Values.EQ-5D-3L 与 EQ-5D-5L 健康值的头对头比较。
Pharmacoeconomics. 2018 Jun;36(6):715-725. doi: 10.1007/s40273-018-0647-0.
7
Health-related quality of life variations by sociodemographic factors and chronic conditions in three metropolitan cities of South Asia: the CARRS study.南亚三个大城市中社会人口因素和慢性病导致的健康相关生活质量差异:CARRS研究
BMJ Open. 2017 Oct 15;7(10):e018424. doi: 10.1136/bmjopen-2017-018424.
8
Normative values of EQ-5D-5L: in a Spanish representative population sample from Spanish Health Survey, 2011.EQ-5D-5L的规范值:来自2011年西班牙健康调查的西班牙代表性人群样本
Qual Life Res. 2016 May;25(5):1313-21. doi: 10.1007/s11136-015-1164-7. Epub 2015 Oct 19.
9
Does diabetes have an impact on health-state utility? a study of Asians in Singapore.糖尿病对健康状态效用有影响吗?一项针对新加坡亚裔的研究。
Patient. 2014;7(3):329-37. doi: 10.1007/s40271-014-0059-y.
10
Are patients' judgments of health status really different from the general population?患者对健康状况的判断真的与一般人群不同吗?
Health Qual Life Outcomes. 2011 May 11;9:31. doi: 10.1186/1477-7525-9-31.
Qual Life Res. 1996 Dec;5(6):521-31. doi: 10.1007/BF00439226.
4
Inconsistency and health state valuations.不一致性与健康状态评估。
Soc Sci Med. 1996 Feb;42(4):609-15. doi: 10.1016/0277-9536(95)00161-1.
5
Measuring preferences for health states worse than death.
Med Decis Making. 1994 Jan-Mar;14(1):9-18. doi: 10.1177/0272989X9401400102.
6
Measuring health status in the community: a comparison of methods.衡量社区中的健康状况:方法比较
J Epidemiol Community Health. 1994 Feb;48(1):86-91. doi: 10.1136/jech.48.1.86.
7
Validity of Euroqol--a generic health status instrument--in patients with rheumatoid arthritis. Economic and Health Outcomes Research Group.欧洲五维度健康量表(一种通用健康状况工具)在类风湿关节炎患者中的效度。经济与健康结果研究小组。
Br J Rheumatol. 1994 Jul;33(7):655-62. doi: 10.1093/rheumatology/33.7.655.
8
The time trade-off technique: how do the valuations of breast cancer patients compare to those of other groups?时间权衡技术:乳腺癌患者的估值与其他群体相比如何?
Qual Life Res. 1994 Aug;3(4):257-65. doi: 10.1007/BF00434899.
9
The effect of past and present illness experience on the valuations of health states.过去和现在的疾病经历对健康状态估值的影响。
Med Care. 1995 Apr;33(4 Suppl):AS255-63.
10
Weights for scoring the quality of well-being instrument among rheumatoid arthritics. A comparison to general population weights.
Med Care. 1986 Nov;24(11):973-80. doi: 10.1097/00005650-198611000-00001.